0.02 KE), at every four weeks, repeated 4 times

2 trials

Sponsors

Department of Gastroenterological Surgery I, Hokkaido University Graduated School of Medicine, Department of Breast and Endocrine Surgery, Hokkaido University Hospital

Conditions

A phase II clinical study of cancer vaccine with Survivin helper peptide for patients with advanced/recurrent breast cancersSurvivin-expressing advanced/recurrent colorectal cancer patients or patients who refuse standard cancer therapy

Phase 2

A phase II clinical study of cancer vaccine with Survivin helper peptide for patients with advanced/recurrent breast cancers

Active, not recruitingJPRN-UMIN000007507

Department of Breast and Endocrine Surgery, Hokkaido University HospitalA phase II clinical study of cancer vaccine with Survivin helper peptide for patients with advanced/recurrent breast cancers

Start: 2012-03-01Target: 40Updated: 2026-06-29

A phase II clinical study of cancer vaccine with Survivin helper peptide for patients with advanced/recurrent colorectal cancers

Active, not recruitingJPRN-UMIN000007506

Department of Gastroenterological Surgery I, Hokkaido University Graduated School of MedicineSurvivin-expressing advanced/recurrent colorectal cancer patients or patients who refuse standard cancer therapy

Start: 2012-03-01Target: 35Updated: 2026-06-29